Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$234M |
| 2 |
eBay
EBAY
|
+$223M |
| 3 |
Walt Disney
DIS
|
+$189M |
| 4 |
Humana
HUM
|
+$184M |
| 5 |
DXC Technology
DXC
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$236M |
| 2 |
Citizens Financial Group
CFG
|
+$157M |
| 3 |
Applied Materials
AMAT
|
+$156M |
| 4 |
Huntsman Corp
HUN
|
+$154M |
| 5 |
STI
SunTrust Banks, Inc.
STI
|
+$151M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.97% |
| 2 | Technology | 16.56% |
| 3 | Industrials | 15.08% |
| 4 | Healthcare | 12.53% |
| 5 | Consumer Discretionary | 12.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
LendingTree
TREE
$436M
| $561K | ﹤0.01% |
3,255
+1,254
| +63% | +$189K |
|
|
MDCO
1852
DELISTED
Medicines Co
MDCO
| $561K | ﹤0.01% |
14,772
+6,817
| +86% | +$304K |
|
|
KMG
1853
DELISTED
KMG Chemicals Inc
KMG
| $561K | ﹤0.01% |
11,530
+1,467
| +15% | +$75.2K |
|
1854
Veeco
VECO
$2.81B
| $559K | ﹤0.01% |
20,075
+12,005
| +149% | +$369K |
|
|
PES
1855
DELISTED
Pioneer Energy Services Corp.
PES
| $554K | ﹤0.01% |
270,045
-178,182
| -40% | -$512K |
|
|
ALJ
1856
DELISTED
Alon USA Energy Inc
ALJ
| $548K | ﹤0.01% |
41,127
| – | – |
|
1857
Otter Tail
OTTR
$3.84B
| $546K | ﹤0.01% |
13,800
-4,647
| -25% | -$183K |
|
|
PBPB
1858
DELISTED
Potbelly
PBPB
| $543K | ﹤0.01% |
47,254
-1,654
| -3% | -$20.2K |
|
|
NLSN
1859
DELISTED
Nielsen Holdings plc
NLSN
| $541K | ﹤0.01% |
13,999
-11,534
| -45% | -$458K |
|
1860
Insulet
PODD
$10.4B
| $539K | ﹤0.01% |
+10,504
| New | +$456K |
|
1861
Generac Holdings
GNRC
$11.8B
| $538K | ﹤0.01% |
14,897
+3,718
| +33% | +$133K |
|
1862
SiriusPoint
SPNT
$2.8B
| $536K | ﹤0.01% |
38,532
-3,574
| -8% | -$45.4K |
|
|
BSMX
1863
DELISTED
Banco Santander México, S, A., Institución de Banca Múltiple, Grupo Financiero Santander México
BSMX
| $535K | ﹤0.01% |
55,529
-51,562
| -48% | -$477K |
|
|
NXTM
1864
DELISTED
NxStage Medical Inc.
NXTM
| $534K | ﹤0.01% |
21,312
+6,598
| +45% | +$163K |
|
1865
OneSpan
OSPN
$579M
| $530K | ﹤0.01% |
36,955
+9,648
| +35% | +$132K |
|
|
SEM
1866
DELISTED
Select Medical
SEM
| $530K | ﹤0.01% |
64,075
-78,527
| -55% | -$589K |
|
|
JOBS
1867
DELISTED
51job Inc
JOBS
| $529K | ﹤0.01% |
11,828
| – | – |
|
1868
Service Corp International
SCI
$11.5B
| $526K | ﹤0.01% |
15,735
| – | – |
|
1869
CubeSmart
CUBE
$9.25B
| $524K | ﹤0.01% |
21,803
-10,275
| -32% | -$260K |
|
|
PNK
1870
DELISTED
Pinnacle Entertainment Inc.
PNK
| $524K | ﹤0.01% |
26,517
+10,752
| +68% | +$216K |
|
|
PEI
1871
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $524K | ﹤0.01% |
3,086
-104
| -3% | -$19.4K |
|
|
CALA
1872
DELISTED
Calithera Biosciences, Inc
CALA
| $522K | ﹤0.01% |
+1,758
| New | +$470K |
|
|
HF
1873
DELISTED
HFF Inc.
HF
| $521K | ﹤0.01% |
14,992
+5,062
| +51% | +$156K |
|
|
GNCMA
1874
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
| $521K | ﹤0.01% |
14,206
-6,718
| -32% | -$243K |
|
1875
Northwest Bancshares
NWBI
$2.27B
| $520K | ﹤0.01% |
33,316
-13,458
| -29% | -$215K |
|
Similar funds
Cliff Asness's Q2 2017 Portfolio in Review
As of Q2 2017, Cliff Asness held 2,306 positions worth $75.6B, up 0.44% from $75.2B the previous quarter. Its ten largest holdings account for 9.2% of the portfolio.
Cliff Asness's Q2 2017 filing shows 139 new, 928 increased, 1,013 reduced and 118 closed positions. Its largest new stake was DXC Technology: 2,594,054 shares worth $172M. The largest sale was Wells Fargo, an estimated $236M.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 18% a quarter earlier, followed by Technology and Industrials.
- Cliff Asness's largest Q2 2017 buy was DXC Technology: 2,594,054 shares worth $172M.
- Cliff Asness added most to Gilead Sciences in Q2 2017, an estimated $234M increase.
- Cliff Asness's biggest Q2 2017 reduction was Wells Fargo, cutting an estimated $236M.
- Cliff Asness fully exited Computer Sciences in Q2 2017, selling an estimated $77.8M.
- Cliff Asness's ten largest holdings make up 9.2% of its $75.6B portfolio in Q2 2017.
- Cliff Asness opened 139 new positions and closed 118 in Q2 2017.
- Cliff Asness's portfolio value rose 0.44% quarter-over-quarter to $75.6B.
Based on AQR Capital Management's 13F filing for Q2 2017, filed 14 Aug 2017.